| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3163777 | Oral Oncology | 2016 | 5 Pages |
•Arginine-enhanced formulas may improve post-operative outcomes.•We compared nutrition supplementation in high-risk head and neck surgical patients.•Enhanced nutrition is associated with decreased length of stay and fistula formation.•Perioperative immunonutrition may improve clinical outcomes and healthcare savings.
SummaryObjectivesInvestigate both the utility and feasibility of perioperative nutritional supplementation with an arginine-enriched immunonutrition formula to high-risk head and neck cancer surgical patients and examine its effects on acute post-operative clinical outcomes.Materials & MethodsThis prospective, non-randomized, interventional cohort study compared high-risk head and neck cancer surgical patients who consumed a pre- and post-operative arginine-based nutritional supplement to those that did not. Outcome measures included post-operative complications, length of hospitalization, readmission rates and measurement of nutritional biomarkers.Results195 high-risk head and neck cancer surgical patients were enrolled. 59% of the patients used the nutritional supplement, 41% did not. Of the 80 patients who did not receive the immunonutrition formula, 38 (47.5%) experienced post-operative complications of all types as compared to 29 of the 115 (25.2%) patients who did consume the product (p = 0.0021). Pharyngeal leaks or fistulas were the most common post-operative complications in both groups and more common in patients who did not receive supplementation (p = 0.007). Length of stay was on average 2.8 days longer in patients who did not have enhanced nutrition (p = 0.02), while readmission rates between the two groups were similar (p = 0.91). Measurements of nutritional biomarkers were not reported secondary to low collection rates.ConclusionEnhanced perioperative nutrition may result in significant reductions of post-operative fistula formations and decreased length of stay in a high-risk head and neck cancer population, even in the setting of poor compliance. The potential quality improvement in both patient care and healthcare cost is both real and significant.
